# Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

> **NCT03968588** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 108 (actual)

## Conditions studied

- Disorder Related to Renal Transplantation

## Interventions

- **DRUG:** Tacrolimus(reduced), Mycophenolate mofetil(standard)
- **DRUG:** Tacrolimus(standard), Mycophenolate mofetil(reduced)

## Key facts

- **NCT ID:** NCT03968588
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-29
- **Primary completion:** 2016-11-11
- **Final completion:** 2017-06-14
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03968588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03968588, "Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03968588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*